Wealthfront Advisers LLC Has $6.73 Million Stock Holdings in MetLife, Inc. $MET

Wealthfront Advisers LLC lowered its holdings in shares of MetLife, Inc. (NYSE:MET) by 10.0% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 81,704 shares of the financial services provider’s stock after selling 9,050 shares during the period. Wealthfront Advisers LLC’s holdings in MetLife were worth $6,730,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Quaker Wealth Management LLC boosted its stake in shares of MetLife by 198.2% in the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 672 shares in the last quarter. Evolution Wealth Management Inc. acquired a new stake in MetLife in the second quarter valued at approximately $35,000. Salomon & Ludwin LLC increased its holdings in shares of MetLife by 95.4% during the third quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock worth $35,000 after buying an additional 206 shares in the last quarter. True Wealth Design LLC lifted its stake in shares of MetLife by 564.1% in the 3rd quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 361 shares during the last quarter. Finally, MTM Investment Management LLC bought a new stake in MetLife during the 2nd quarter worth $37,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MET opened at $78.89 on Thursday. The company has a current ratio of 0.20, a quick ratio of 0.18 and a debt-to-equity ratio of 0.50. The firm’s fifty day simple moving average is $78.96 and its two-hundred day simple moving average is $78.81. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $87.39. The stock has a market capitalization of $51.98 billion, a P/E ratio of 16.79, a price-to-earnings-growth ratio of 0.71 and a beta of 0.77.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $2.34 by $0.24. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The firm’s revenue for the quarter was up 27.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.08 earnings per share. As a group, analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd will be issued a dividend of $0.5675 per share. The ex-dividend date is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife’s dividend payout ratio is currently 48.30%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on MET shares. Wells Fargo & Company lifted their price target on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th. Evercore set a $97.00 target price on shares of MetLife and gave the stock an “in-line” rating in a research report on Tuesday, January 6th. Evercore ISI set a $95.00 price target on shares of MetLife in a research report on Tuesday. Morgan Stanley set a $101.00 price target on shares of MetLife and gave the stock an “overweight” rating in a report on Monday, December 15th. Finally, Weiss Ratings downgraded MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus target price of $95.58.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.